DrugPatentWatch Database Preview
Drugs in Development Information for Sirna-027
Email this page to a colleague
What is the drug development status for Sirna-027?
Sirna-027 is an investigational drug.
There have been 26 clinical trials for Sirna-027.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.
The most common disease conditions in clinical trials are Pancreatic Neoplasms, Pachyonychia Congenita, and Nails, Malformed. The leading clinical trial sponsors are National Cancer Institute (NCI), Dicerna Pharmaceuticals, Inc., and Nitto Denko Corporation.
There are three US patents protecting this investigational drug and two hundred and fifty-seven international patents.
Summary for Sirna-027
| US Patents | 3 |
| International Patents | 257 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-01-01) |
| Vendors | 0 |
Recent Clinical Trials for Sirna-027
| Title | Sponsor | Phase |
|---|---|---|
| Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma | Amarex Clinical Research | Phase 2 |
| Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma | Sirnaomics | Phase 2 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pozelimab in Combination With Cemdisiran in Healthy Adult Volunteers | Alnylam Pharmaceuticals | Phase 1 |
Clinical Trial Summary for Sirna-027
Top disease conditions for Sirna-027
Top clinical trial sponsors for Sirna-027
US Patents for Sirna-027
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Sirna-027 | Try Before You Buy | Recombinant vectors | Tocagen Inc. (San Diego, CA) | Try Before You Buy |
| Sirna-027 | Try Before You Buy | Compositions and methods to control angiogenesis with cupredoxins | The Board of Trustees of the University of Illinois (Urbana, IL) | Try Before You Buy |
| Sirna-027 | Try Before You Buy | Recombinant vectors | Tocagen Inc. (San Diego, CA) | Try Before You Buy |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Sirna-027
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Sirna-027 | Australia | AU2009303690 | 2028-09-26 | Try Before You Buy |
| Sirna-027 | Brazil | BRPI0919113 | 2028-09-26 | Try Before You Buy |
| Sirna-027 | Canada | CA2738472 | 2028-09-26 | Try Before You Buy |
| Sirna-027 | China | CN102227501 | 2028-09-26 | Try Before You Buy |
| Sirna-027 | China | CN102227503 | 2028-09-26 | Try Before You Buy |
| Sirna-027 | China | CN105274125 | 2028-09-26 | Try Before You Buy |
| Sirna-027 | China | CN105624193 | 2028-09-26 | Try Before You Buy |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
